Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Debt: 2011-2018

Historic Total Debt for EyePoint Pharmaceuticals (EYPT) over the last 2 years, with Jun 2018 value amounting to $17.3 million.

  • EyePoint Pharmaceuticals' Total Debt rose 148.65% to $32.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $32.0 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $17.3 million for FY2018, which is N/A change from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Total Debt stood at $17.3 million, which was up 10,081.76% from $170,000 recorded in FY2011.
  • EyePoint Pharmaceuticals' 5-year Total Debt high stood at $17.3 million for FY2018, and its period low was $17.3 million during FY2018.
  • Its 1-year average for Total Debt is $17.3 million, with a median of $17.3 million in 2018.